Werewolf Therapeutics
Signal active
Organization
Contact Information
Overview
Werewolf Therapeutics is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.
About
Industries
Biotechnology, Life Science, Therapeutics, Oncology
Founded
2017
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Werewolf Therapeutics headquartered in United States, North America, operates in the Biotechnology, Life Science, Therapeutics, Oncology sector. The company focuses on Biotechnology and has secured $8.6B in funding across 48 round(s). With a team of 11-50 employees, Werewolf Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Secondary - Werewolf Therapeutics, raised $50.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
0
Lead Investors
0
Total Funding Amount
$178.2M
Details
2
Werewolf Therapeutics has raised a total of $178.2M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Early Stage Venture | 56.2M | ||
| 2021 | Early Stage Venture | 72.0M |
Investors
Werewolf Therapeutics is funded by 25 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| DC Investment Partners | - | FUNDING ROUND - DC Investment Partners | 72.0M |
| Longwood Fund | - | FUNDING ROUND - Longwood Fund | 72.0M |
| Werewolf Therapeutics | - | FUNDING ROUND - Werewolf Therapeutics | 72.0M |
| MPM Capital | - | FUNDING ROUND - MPM Capital | 72.0M |
Recent Activity
There is no recent news or activity for this profile.